Dyspareunia Clinical Trials

13 recruiting

Dyspareunia Trials at a Glance

13 actively recruiting trials for dyspareunia are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Washington D.C., Québec, and Barcelona. Lead sponsors running dyspareunia studies include Centre Hospitalier Universitaire Saint Pierre, Hospital Clinic of Barcelona, and Center for Vulvovaginal Disorders.

Browse dyspareunia trials by phase

Treatments under study

About Dyspareunia Clinical Trials

Looking for clinical trials for Dyspareunia? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dyspareunia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dyspareunia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Not Applicable

Effectiveness of Radiofrequency Combined With Ultrasound for the Treatment of Postpartum Dyspareunia

Dyspareunia
Institut Investigacio Sanitaria Pere Virgili34 enrolled1 locationNCT07504991
Recruiting
Not Applicable

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

Sexual FunctionQuality of LifeGenitourinary Syndrome of Menopause+5 more
Mucosa Innovations, S.L.80 enrolled1 locationNCT06962345
Recruiting
Phase 2

Topical Ketotifen 0.25% for Secondary Vestibulodynia

VulvodyniaProvoked VestibulodyniaSecondary Provoked Vestibulodynia+4 more
Center for Vulvovaginal Disorders54 enrolled3 locationsNCT07257029
Recruiting
Not Applicable

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

Sexual DysfunctionRadiation ToxicityDyspareunia+1 more
Indiana University20 enrolled3 locationsNCT06059586
Recruiting
Not Applicable

Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum.

Dyspareunia
Hospital Clinic of Barcelona110 enrolled1 locationNCT05417334
Recruiting
Not Applicable

Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women

MenopauseGenitourinary Syndrome of MenopauseDyspareunia
Instituto Médico Tecnológico SL90 enrolled1 locationNCT06710002
Recruiting
Not Applicable

VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia

DyspareuniaVestibulodyniaPelvic Pain+3 more
Medstar Health Research Institute60 enrolled1 locationNCT06840314
Recruiting
Not Applicable

Biomodulation and Rehabilitation Interventions to TarGet Pelvic Health

VulvodyniaDyspareuniaProvoked Vestibulodynia
University of Ottawa240 enrolled2 locationsNCT06660212
Recruiting
Not Applicable

Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach

Quality of LifeSexual DysfunctionPathology+8 more
Jean Dubuisson62 enrolled1 locationNCT05761275
Recruiting
Not Applicable

Use of TDCS Stimulation in Neurological and Gynaecological Conditions

StrokeSpinal Cord DiseasesEndometriosis+4 more
Poznan University of Physical Education300 enrolled1 locationNCT06891690
Recruiting
Not Applicable

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment

Vulvo Vaginal AtrophyGenitourinary Syndrome of Menopause (GSM)Vaginal Atrophy in Breast Cancer Patients+4 more
Centre Hospitalier Universitaire Saint Pierre160 enrolled1 locationNCT06828640
Recruiting
Not Applicable

Pelvic Health Rehabilitation After Breast and Gynecologic Cancer

Breast Cancer FemaleGynecologic CancersIncontinence+4 more
Laval University20 enrolled2 locationsNCT06822582
Recruiting
Phase 3

Randomised, double-blinded, placebo-controlled trial assessing the efficacy of Mi-Gel® in the treatment of women with vulval pain / entry dyspareunia.

Entry dyspareuniaVulval pain
TA Pharma Pty Ltd174 enrolled1 locationACTRN12624001210561